These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 2927059

  • 1. Serum phospholipase A in hematological diseases.
    Hiefinger RT, Guder WG, Hoffmann GE.
    Klin Wochenschr; 1989 Feb 01; 67(3):222-4. PubMed ID: 2927059
    [Abstract] [Full Text] [Related]

  • 2. Lactic dehydrogenase estimation in haematological malignancies.
    Flanagan NG, Ridway JC, Platt CC, Rowlands AJ, Whitson A.
    Clin Lab Haematol; 1989 Feb 01; 11(1):17-26. PubMed ID: 2495880
    [Abstract] [Full Text] [Related]

  • 3. Muramidase in myeloproliferative disorders terminating in acute leukemia.
    Skarin AT, Matsuo Y, Moloney WC.
    Cancer; 1972 May 01; 29(5):1336-42. PubMed ID: 4502496
    [No Abstract] [Full Text] [Related]

  • 4. Neutrophil 5-nucleotidase reaction in chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, and polycythemia vera.
    Tsavaris NB, Pangalis GA.
    Ann Hematol; 1998 Jan 01; 76(1):1-5. PubMed ID: 9486917
    [Abstract] [Full Text] [Related]

  • 5. Cytochemical demonstration of dihydrofolate reductase in leukaemia and other haematological diseases.
    Tzortzatou F.
    Scand J Haematol; 1977 Jul 01; 19(1):5-13. PubMed ID: 268023
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies.
    Wiernik PH, Serpick AA.
    Am J Med; 1969 Mar 01; 46(3):330-43. PubMed ID: 4888852
    [No Abstract] [Full Text] [Related]

  • 7. Serum muramidase in haematological disorders: diagnostic value in neoplastic states.
    Firkin FC.
    Aust N Z J Med; 1972 Feb 01; 2(1):28-33. PubMed ID: 4502715
    [No Abstract] [Full Text] [Related]

  • 8. [Isoenzymes of fructosephosphate aldolase in the serum of patients with various malignant hemopathies. Isoenzymes of fructosephosphate aldolase. IX].
    Dikow AL, Genova V.
    Z Klin Chem Klin Biochem; 1969 Nov 01; 7(6):614-6. PubMed ID: 4903945
    [No Abstract] [Full Text] [Related]

  • 9. Muramidase activity in leukemia and myeloproliferative disorders.
    Skarin AT, Matsuo Y, Moloney WC.
    Oncology; 1973 Nov 01; 27(5):406-14. PubMed ID: 4515747
    [No Abstract] [Full Text] [Related]

  • 10. [The significance of muramidase (lysozyme) determinations in hematologic diseases].
    Mets T, Carlier A, Van Hove W.
    Ned Tijdschr Geneeskd; 1976 Nov 20; 120(47):2039-44. PubMed ID: 1070575
    [No Abstract] [Full Text] [Related]

  • 11. MYELOPROLIFERATIVE SYNDROME; EVALUATION OF MYELOSCLEROSIS AND CHRONIC MYELOGENOUS LEUKEMIA TO POLYCYTHEMIA VERA.
    LOPAS H, JOSEPHSON AM.
    Arch Intern Med; 1964 Dec 20; 114():754-9. PubMed ID: 14211587
    [No Abstract] [Full Text] [Related]

  • 12. [Lysozyme in hematologic diseases].
    Zittoun J, Zittoun R.
    Sem Hop; 1975 Jan 20; 51(4):247-52. PubMed ID: 167445
    [Abstract] [Full Text] [Related]

  • 13. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J, Giles F, O'Brien S, Thomas D, Albitar M, Rios MB, Talpaz M, Garcia-Manero G, Faderl S, Letvak L, Salvado A, Kantarjian H.
    Cancer; 2003 Jun 01; 97(11):2760-6. PubMed ID: 12767088
    [Abstract] [Full Text] [Related]

  • 14. Myelosclerosis: a study of a condition also known as myelofibrosis, aleuchaemic myelosis, agnogenic myeloid metaplasia, and other titles.
    ROBSON HN.
    Australas Ann Med; 1953 Nov 01; 2(2):170-8. PubMed ID: 13115298
    [No Abstract] [Full Text] [Related]

  • 15. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera.
    FRANZEN S, STRENGER G, ZAJICEK J.
    Acta Haematol; 1961 Nov 01; 26():182-93. PubMed ID: 13894731
    [No Abstract] [Full Text] [Related]

  • 16. [ENERGY METABOLISM OF HUMAN THROMBOCYTES UNDER NORMAL CONDITIONS AND IN POLYCYTHEMIA AND CHRONIC MYELOSIS].
    EGOROVA VA, BLINOVA AI, SEITS IF.
    Vopr Med Khim; 1965 Nov 01; 11():35-41. PubMed ID: 14339546
    [No Abstract] [Full Text] [Related]

  • 17. [Study on correlation and clinical significance of superoxide dismutase (SOD) activity and content in 102 patients with leukemia].
    Zhu CS, Zhang CY, Weng WQ.
    Zhonghua Zhong Liu Za Zhi; 1994 Jan 01; 16(1):39-42. PubMed ID: 8033747
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the concentration of neutrophils and monocytes in venous blood.
    Bain BJ, Wickramasinghe SN.
    Acta Haematol; 1976 Jan 01; 55(2):89-94. PubMed ID: 816147
    [Abstract] [Full Text] [Related]

  • 19. The elevated peripheral white blood count.
    Bolwell BJ.
    Cleve Clin J Med; 1993 Jan 01; 60(4):267-8. PubMed ID: 8339449
    [No Abstract] [Full Text] [Related]

  • 20. [Activity of acid phosphatase in blood cells and bone marrow cells in some internal diseases].
    Orzechowska-Juzwenko K, Kotlarek-Haus S, Brodzka W.
    Acta Haematol Pol; 1972 Jan 01; 3(3):229-35. PubMed ID: 4509821
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.